Search filters

List of works by Paola Indovina

Abrogating G₂/M checkpoint through WEE1 inhibition in combination with chemotherapy as a promising therapeutic approach for mesothelioma

scientific article published on 14 January 2014

Antitumor activity of new pyrazolo[3,4-d]pyrimidine SRC kinase inhibitors in Burkitt lymphoma cell lines and its enhancement by WEE1 inhibition

scientific article

Antitumoral potential, antioxidant activity and carotenoid content of two Southern Italy tomato cultivars extracts: San Marzano and Corbarino

scientific article published on 10 May 2017

Correction: P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma

scientific article published on 16 October 2020

Downregulation and aberrant promoter methylation of p16INK4A: a possible novel heritable susceptibility marker to retinoblastoma

scientific article published in April 2010

Mass spectrometry-based proteomics: the road to lung cancer biomarker discovery

scientific article

P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma

scientific article published on 14 September 2020

Pharmacological Inhibition of WEE1 Potentiates the Antitumoral Effect of the dl922-947 Oncolytic Virus in Malignant Mesothelioma Cell Lines

scientific article published on 04 October 2020

Pharmacological targeting of p53 through RITA is an effective antitumoral strategy for malignant pleural mesothelioma

scientific article published on 17 December 2013

RBL2/p130 is a direct AKT target and is required to induce apoptosis upon AKT inhibition in lung cancer and mesothelioma cell lines

scientific article published on 2 April 2018

SRC Family Kinase Inhibition in Ewing Sarcoma Cells Induces p38 MAP Kinase-Mediated Cytotoxicity and Reduces Cell Migration.

scientific article published on 02 April 2016

SRC family kinase (SFK) inhibition reduces rhabdomyosarcoma cell growth in vitro and in vivo and triggers p38 MAP kinase-mediated differentiation

scientific article published in May 2015

SRC family kinase inhibition through a new pyrazolo[3,4-d]pyrimidine derivative as a feasible approach for glioblastoma treatment

scientific article published on May 2015

pRb2/p130 localizes to the cytoplasm in diffuse gastric cancer

scientific article published in April 2015